Bridging Science & Strategy^™

We help the global life science community make confident decisions, build value, and bring life-changing innovations to clinicians and patients.

Learn more about Putnam

What we do.

Putnam bridges the highest levels of scientific and strategic excellence across the product development and commercialization lifecycle.

Discover our solutions

Commercial

Value, Pricing & Access

Medical & Scientific Affairs

Meet our experts.

At Putnam, our global team of rigorously trained and highly engaged scientists and strategists dig deep to solve your most complex challenges and advance your innovations.

Get to know our people

By the numbers.

For more than 30 years, Putnam has maximized the human impact and commercial success of client innovations with a bespoke approach and globally diverse team.

500+

Team members

Our growing global team is 100% focused on life sciences with deep industry experience and niche expertise.

10

Global offices

We continue to expand our global footprint to deliver more local presence, perspective, and value to clients.

45+

Therapeutic areas

Since 2000, we’ve delivered an unmatched breadth and depth of expertise across more than 45 therapeutic areas.

Centers of Excellence.

We help you navigate complexities and develop bold strategies with centers of excellence in advanced clinical technologies, financial modeling and forecasting, and integrated insights.

See our Centers of Excellence

Latest thinking.

Get the latest insights and perspectives from our experts.

View all of our resources

Lessons to optimize EMA regulatory success using single-arm trials in oncology

We set out to understand the likelihood of regulatory approval of oncology-based single-arm trials by the European Medical Agency (EMA).

Medicare Price Negotiation: Putnam’s Round One Picks

As provisions of the Inflation Reduction Act (IRA) of 2022 begin to take effect, Putnam continues to analyze the implications…

New Principal out of London Joins Putnam

Putnam is pleased to announce the addition of Stephen McGarry to the team. Steve started with Putnam in June 2023 as a...

Distributional cost‑effectiveness analysis of treatments for non‑small cell lung cancer

Putnam aimed to conduct an aggregate DCEA of two NSCLC treatments recommended by NICE, and identify key drivers of the analysis.

Careers at Putnam.

Are you seeking an empowering team, collaborative culture, and meaningful work that shapes the future of human health? We could be your next move. View our roles to learn, grow, and excel in an environment that will inspire you to be your best.

Open roles

Centers of Excellence